Reactive Oxygen Species in Endothelial Function: From Disease to Adaptation

Circulation Journal

Volumn 79, Issue 6, 2015, Pages 1145-1155

  Craige, Siobhan M ^a   Kant, Shashi ^a   Keaney, John F ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Angiogenesis; Endothelial dysfunction; Endothelial function; Oxidative stress; Reactive oxygen species

Indexed keywords

ANGIOPOIETIN; BONE MORPHOGENETIC PROTEIN; CYCLIC GMP; CYCLIC NUCLEOTIDE DEPENDENT PROTEIN KINASE; GUANOSINE TRIPHOSPHATE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MATRIX METALLOPROTEINASE; MITOGEN ACTIVATED PROTEIN KINASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PLATELET DERIVED GROWTH FACTOR; PROTEIN KINASE B; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 1; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4; SUPEROXIDE DISMUTASE; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 4; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2; ACETYLCHOLINE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIUM DERIVED RELAXING FACTOR;

ANGIOGENESIS; BLOOD VESSEL TONE; CARDIOVASCULAR RISK; CELL FUNCTION; CELL MIGRATION; DISEASE ASSOCIATION; ENDOTHELIUM; HUMAN; IMMUNOLOGICAL TOLERANCE; INFLAMMATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION; SMOOTH MUSCLE RELAXATION; THROMBOCYTE AGGREGATION; ADAPTATION; ANIMAL; CARDIOVASCULAR DISEASE; DRUG EFFECTS; HYPOXIA; IMMUNOLOGY; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; VASCULAR ENDOTHELIUM; VASCULAR RESISTANCE; VASCULITIS; VASODILATATION;

ACETYLCHOLINE; ADAPTATION, PHYSIOLOGICAL; ANIMALS; CARDIOVASCULAR DISEASES; ENDOTHELIUM, VASCULAR; ENDOTHELIUM-DEPENDENT RELAXING FACTORS; HUMANS; HYPOXIA; NADPH OXIDASE; NEOVASCULARIZATION, PHYSIOLOGIC; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; VASCULAR RESISTANCE; VASCULITIS; VASODILATION;

EID: 84930074903     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-15-0464     Document Type: Review

References (131)

1. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980; 288: 373-376.
2. Murakami M, Nguyen LT, Hatanaka K, Schachterle W, Chen PY, Zhuang ZW, et al. FGF-dependent regulation of VEGF receptor 2 expression in mice. J Clin Invest 2011; 121: 2668 – 2678.
3. Ludmer PL, Selwyn AP, Shook TL, Wayne RR, Mudge GH, Alexander RW, et al. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N Engl J Med 1986; 315: 1046 – 1051.
4. Huang PL, Huang Z, Mashimo H, Bloch KD, Moskowitz MA, Bevan JA, et al. Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature 1995; 377: 239 – 242.
5. Flammer AJ, Anderson T, Celermajer DS, Creager MA, Deanfield J, Ganz P, et al. The assessment of endothelial function: From research into clinical practice. Circulation 2012; 126: 753 – 767.
6. Storkebaum E, Carmeliet P. Paracrine control of vascular innervation in health and disease. Acta Physiol (Oxf) 2011; 203: 61 – 86.
7. Ignarro LJ, Buga GM, Wood KS, Byrns RE, Chaudhuri G. Endo thelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci USA 1987; 84: 9265 – 9269.
8. Ignarro LJ, Byrns RE, Buga GM, Wood KS. Endothelium-derived relaxing factor from pulmonary artery and vein possesses pharmacologic and chemical properties identical to those of nitric oxide radical. Circ Res 1987; 61: 866 – 879.
9. Feil R, Lohmann SM, de Jonge H, Walter U, Hofmann F. Cyclic GMP-dependent protein kinases and the cardiovascular system: Insights from genetically modified mice. Circ Res 2003; 93: 907 – 916.
10. Sessa WC. eNOS at a glance. J Cell Sci 2004; 117: 2427 – 2429.
11. Stocker R, Keaney JF. Role of oxidative modifications in atherosclerosis. Physiol Rev 2004; 84: 1381 – 1478.
12. Thomas SR, Chen K, Keaney JF. Hydrogen peroxide activates endothelial nitric-oxide synthase through coordinated phosphorylation and dephosphorylation via a phosphoinositide 3-kinase-dependent signaling pathway. J Biol Chem 2002; 277: 6017 – 6024.
13. Drummond GR, Cai H, Davis ME, Ramasamy S, Harrison DG. Transcriptional and posttranscriptional regulation of endothelial nitric oxide synthase expression by hydrogen peroxide. Circ Res 2000; 86: 347 – 354.
14. Craige SM, Chen K, Pei Y, Li C, Huang X, Chen C, et al. NADPH oxidase 4 promotes endothelial angiogenesis through endothelial nitric oxide synthase activation. Circulation 2011; 124: 731 – 740.
15. Schröder K, Zhang M, Benkhoff S, Mieth A, Pliquett R, Kosowski J, et al. Nox4 is a protective reactive oxygen species generating vascular NADPH oxidase. Circ Res 2012; 110: 1217 – 1225.
16. McCord JM, Fridovich I. Superoxide dismutase: An enzymic function for erythrocuprein (hemocuprein). J Biol Chem 1969; 244: 6049– 6055.
17. Huang TT, Carlson EJ, Raineri I, Gillespie AM, Kozy H, Epstein CJ. The use of transgenic and mutant mice to study oxygen free radical metabolism. Ann NY Acad Sci 1999; 893: 95 – 112.
18. Harman D. Aging: A theory based on free radical and radiation chemistry. J Gerontol 1956; 11: 298 – 300.
19. Sies H. Oxidative stress: Oxidants and antioxidants. Exp Physiol 1997; 82: 291 – 295.
20. Sundaresan M, Yu ZX, Ferrans VJ, Irani K, Finkel T. Requirement for generation of H2O2 for platelet-derived growth factor signal transduction. Science 1995; 270: 296 – 299.
21. Zhang ZY, Dixon JE. Active site labeling of the Yersinia protein tyrosine phosphatase: The determination of the pKa of the active site cysteine and the function of the conserved histidine 402. Biochemistry 1993; 32: 9340 – 9345.
22. Lohse DL, Denu JM, Santoro N, Dixon JE. Roles of aspartic acid 181 and serine-222 in intermediate formation and hydrolysis of the mammalian protein-tyrosine-phosphatase PTP1. Biochemistry 1997; 36: 4568 – 4575.
23. Nisimoto Y, Diebold BA, Constentino-Gomes D, Lambeth JD. Nox4: A hydrogen peroxide-generating oxygen sensor. Biochemistry 2014; 53: 5111 – 5120.
24. Takac I, Schröder K, Zhang L, Lardy B, Anilkumar N, Lambeth JD, et al. The E-loop is involved in hydrogen peroxide formation by the NADPH oxidase Nox4. J Biol Chem 2011; 286: 13304 – 13313.
25. Bedard K, Krause KH. The Nox family of ROS-generating NADPH oxidases: Physiology and pathophysiology. Physiol Rev 2007; 87: 245 – 313.
26. Ago T, Kitazono T, Ooboshi H, Iyama T, Han YH, Takada J, et al. Nox4 as the major catalytic component of an endothelial NAD(P) H oxidase. Circulation 2004; 109: 227 – 233.
27. Dikalov SI, Dikalova AE, Bikineyeva AT, Schmidt HHHW, Harrison DG, Griendling KK. Distinct roles of Nox1 and Nox4 in basal and angiotensin II-stimulated superoxide and hydrogen peroxide production. Free Radic Biol Med 2008; 45: 1340 – 1351.
28. Sorescu D, Weiss D, Lassègue B, Clempus RE, Szöcs K, Sorescu GP, et al. Superoxide production and expression of nox family proteins in human atherosclerosis. Circulation 2002; 105: 1429 – 1435.
29. Sandoo A, van Zanten JJCSV, Metsios GS, Carroll D, Kitas GD. The endothelium and its role in regulating vascular tone. Open Cardiovasc Med J 2010; 4: 302 – 312.
30. Chatterjee S,Fisher AB., Mechanotransduction in the endothelium: Role of membrane proteins and reactive oxygen species in sensing, transduction, and transmission of the signal with altered blood flow. Antioxid Redox Signal 2014; 20: 899 – 913.
31. Brandes RP, Weissmann N, Schröder K. Nox family NADPH oxidases in mechano-transduction: Mechanisms and consequences. Antioxid Redox Signal 2014; 20: 887 – 898.
32. Ting HH, Timimi FK, Boles KS, Creager SJ, Ganz P, Creager MA., Vitamin C improves endothelium-dependent vasodilation in patients with non-insulin-dependent diabetes mellitus. J Clin Invest 1996; 97: 22 – 28.
33. Levine GN, Frei B, Koulouris SN, Gerhard MD, Keaney JF, Vita JA. Ascorbic acid reverses endothelial vasomotor dysfunction in patients with coronary artery disease. Circulation 1996; 93: 1107 – 1113.
34. Gokce N, Keaney JF, Frei B, Holbrook M, Olesiak M, Zachariah BJ, et al. Long-term ascorbic acid administration reverses endothelial vasomotor dysfunction in patients with coronary artery disease. Circulation 1999; 99: 3234 – 3240.
35. Mügge A, Elwell JH, Peterson TE, Harrison DG. Release of intact endothelium-derived relaxing factor depends on endothelial superoxide dismutase activity. Am J Physiol 1991; 260: C219 – C225.
36. Romanowski A, Murray JR, Huston MJ. Effects of hydrogen peroxide on normal and hypertensive rats. Pharm Acta Helv 1960; 35: 354 – 357.
37. Duffy SJ, Gokce N, Holbrook M, Huang A, Frei B, Keaney JF, et al. Treatment of hypertension with ascorbic acid. Lancet 1999; 354: 2048 – 2049.
38. Rajagopalan S, Kurz S, Münzel T, Tarpey M, Freeman BA, Griendling KK, et al. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/ NADPH oxidase activation: Contribution to alterations of vasomotor tone. J Clin Invest 1996; 97: 1916 – 1923.
39. Montezano AC, Touyz RM. : Reactive oxygen species vascular Noxs, and hypertension Focus on translational and clinical research. Antioxid Redox Signal 2014; 20: 164-182.
40. Dikalova A, Clempus R, Lassègue B, Cheng G, McCoy J, Dikalov S, et al. Nox1 overexpression potentiates angiotensin II-induced hypertension and vascular smooth muscle hypertrophy in transgenic mice. Circulation 2005; 112: 2668 – 2676.
41. Dikalova AE, Góngora MC, Harrison DG, Lambeth JD, Dikalov S, Griendling KK. Upregulation of Nox1 in vascular smooth muscle leads to impaired endothelium-dependent relaxation via eNOS uncoupling. Am J Physiol Heart Circ Physiol 2010; 299: H673 – H679.
42. Matsuno K, Yamada H, Iwata K, Jin D, Katsuyama M, Matsuki M, et al. Nox1 is involved in angiotensin II-mediated hypertension: A study in Nox1-deficient mice. Circulation 2005; 112: 2677 – 2685.
43. Gavazzi G, Banfi B, Deffert C, Fiette L, Schappi M, Herrmann F, et al. Decreased blood pressure in Nox1-deficient mice. FEBS Lett 2006; 580: 497 – 504.
44. Kanda T, Brown JD, Orasanu G, Vogel S, Gonzalez FJ, Sartoretto J, et al. PPARgamma in the endothelium regulates metabolic responses to high-fat diet in mice. J Clin Invest 2009; 119: 110 – 124.
45. Touyz RM, Mercure C, He Y, Javeshghani D, Yao G, Callera GE, et al. Angiotensin II-dependent chronic hypertension and cardiac hypertrophy are unaffected by gp91phox-containing NADPH oxidase. Hypertension 2005; 45: 530 – 537.
46. Wang HD, Xu S, Johns DG, Du Y, Quinn MT, Cayatte AJ, et al. Role of NADPH oxidase in the vascular hypertrophic and oxidative stress response to angiotensin II in mice. Circ Res 2001; 88: 947 – 953.
47. Wolin MS, Burke TM. Hydrogen peroxide elicits activation of bovine pulmonary arterial soluble guanylate cyclase by a mechanism associated with its metabolism by catalase. Biochem Biophys Res Commun 1987; 143: 20 – 25.
48. Burke TM, Wolin MS. Hydrogen peroxide elicits pulmonary arterial relaxation and guanylate cyclase activation. Am J Physiol 1987; 252: H721 – H732.
49. Burgoyne JR, Madhani M, Cuello F, Charles RL, Brennan JP, Schröder E, et al. Cysteine redox sensor in PKGIa enables oxidantinduced activation. Science 2007; 317: 1393 – 1397.
50. Zhou Y, Yan H, Guo M, Zhu J, Xiao Q, Zhang L. Reactive oxygen species in vascular formation and development. Oxid Med Cell Longev 2013; 2013: 1 – 14.
51. Faggiotto A, Ross R, Harker L. Studies of hypercholesterolemia in the nonhuman primate: I. Changes that lead to fatty streak formation. Arteriosclerosis 1984; 4: 323 – 340.
52. Faggiotto A, RossR., Studies of hypercholesterolemia in the nonhuman primate: II. Fatty streak conversion to fibrous plaque. Arteriosclerosis 1984; 4: 341 – 356.
53. Ross R. Atherosclerosis: An inflammatory disease. N Engl J Med 1999; 340: 115 – 126.
54. Schwenke DC, Carew TE., Initiation of atherosclerotic lesions in cholesterol-fed rabbits: I. Focal increases in arterial LDL concentration precede development of fatty streak lesions. Arteriosclerosis 1989; 9: 895 – 907.
55. Stanic B, Pandey D, Fulton DJ, Miller FJ. Increased epidermal growth factor-like ligands are associated with elevated vascular nicotinamide adenine dinucleotide phosphate oxidase in a primate model of atherosclerosis. Arterioscler Thromb Vasc Biol 2012; 32: 2452 – 2460.
56. − mice. Am J Physiol Heart Circ Physiol 2010; 298: H24-H32.
57. Sheehan AL, Carrell S, Johnson B, Stanic B, Banfi B, Miller FJ Jr. Atherosclerosis. Atherosclerosis 2011; 216: 321 – 326.
58. Warnholtz A, Nickenig G, Schulz E, Macharzina R, Bräsen JH, Skatchkov M, et al. Increased NADH-oxidase-mediated superoxide production in the early stages of atherosclerosis: Evidence for involvement of the renin-angiotensin system. Circulation 1999; 99: 2027 – 2033.
59. Hathaway CA, Heistad DD, Piegors DJ, Miller FJ. Regression of atherosclerosis in monkeys reduces vascular superoxide levels. Circ Res 2002; 90: 277 – 283.
60. Azumi H, Inoue N, Takeshita S, Rikitake Y, Kawashima S, Hayashi Y, et al. Expression of NADH/NADPH oxidase p22phox in human coronary arteries. Circulation 1999; 100: 1494 – 1498.
61. Guzik TJ, Mussa S, Gastaldi D, Sadowski J, Ratnatunga C, Pillai R, et al. Mechanisms of increased vascular superoxide production in human diabetes mellitus: Role of NAD(P)H oxidase and endothelial nitric oxide synthase. Circulation 2002; 105: 1656 – 1662.
62. Guzik TJ, West NE, Black E, McDonald D, Ratnatunga C, Pillai R, et al. Vascular superoxide production by NAD(P)H oxidase: Association with endothelial dysfunction and clinical risk factors. Circ Res 2000; 86: E85 – E90.
63. Vecchione C, Brandes RP. Withdrawal of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors elicits oxidative stress and induces endothelial dysfunction in mice. Circ Res 2002; 91: 173 – 179.
64. Wagner AH, Köhler T, Rückschloss U, Just I, Hecker M. Improvement of nitric oxide-dependent vasodilatation by HMG-CoA reductase inhibitors through attenuation of endothelial superoxide anion formation. Arterioscler Thromb Vasc Biol 2000; 20: 61 – 69.
65. Bandoh T, Sato EF, Mitani H, Nakashima A, Hoshi K, Inoue M. Antioxidative potential of fluvastatin via the inhibition of nicotinamide adenine dinucleotide phosphate (NADPH) oxidase activity. Biol Pharm Bull 2003; 26: 818 – 822.
66. Margaritis M, Channon KM, Antoniades C. Statins as regulators of redox state in the vascular endothelium: Beyond lipid lowering. Antioxid Redox Signal 2014; 20: 1198 – 1215.
67. Kubes P, Kanwar S, Niu XF, Gaboury JP. Nitric oxide synthesis inhibition induces leukocyte adhesion via superoxide and mast cells. FASEB J 1993; 7: 1293 – 1299.
68. Stokes KY, Clanton EC, Russell JM, Ross CR, Granger DN. NAD(P)H oxidase-derived superoxide mediates hypercholesterolemia-induced leukocyte-endothelial cell adhesion. Circ Res 2001; 88: 499 – 505.
69. Chen XL, Zhang Q, Zhao R, Ding X, Tummala PE, Medford RM. Rac1 and superoxide are required for the expression of cell adhesion molecules induced by tumor necrosis factor-α in endothelial cells. J Pharmacol Exp Ther 2003; 305: 573 – 580.
70. Gertzberg N, Neumann P, Rizzo V, Johnson A. NAD(P)H oxidase mediates the endothelial barrier dysfunction induced by TNF-α. Am J Physiol Lung Cell Mol Physiol 2004; 286: L37 – L48.
71. Li JM, Fan LM, Christie MR, Shah AM. Acute tumor necrosis factor alpha signaling via NADPH oxidase in microvascular endothelial cells: Role of p47phox phosphorylation and binding to TRAF4. Mol Cell Biol 2005; 25: 2320 – 2330.
72. Park HS, Chun JN, Jung HY, Choi C, Bae YS. Role of NADPH oxidase 4 in lipopolysaccharide-induced proinflammatory responses by human aortic endothelial cells. Cardiovasc Res 2006; 72: 447 – 455.
73. Pastore L, Tessitore A, Martinotti S, Toniato E, Alesse E, Bravi MC, et al. Angiotensin II stimulates intercellular adhesion molecule-1 (ICAM-1) expression by human vascular endothelial cells and increases soluble ICAM-1 release in vivo. Circulation 1999; 100: 1646 – 1652.
74. Costanzo A, Moretti F, Burgio VL, Bravi C, Guido F, Levrero M, et al. Endothelial activation by angiotensin II through NFkappaB and p38 pathways: Involvement of NFkappaB-inducible kinase (NIK), free oxygen radicals, and selective inhibition by aspirin. J Cell Physiol 2003; 195: 402 – 410.
75. Hashikabe Y, Suzuki K, Jojima T, Uchida K, Hattori Y. Aldosterone impairs vascular endothelial cell function. J Cardiovasc Phar macol 2006; 47: 609 – 613.
76. Hwang J, Saha A, Boo YC, Sorescu GP, McNally JS, Holland SM, et al. Oscillatory shear stress stimulates endothelial production of O2- from p47phox-dependent NAD(P)H oxidases, leading to monocyte adhesion. J Biol Chem 2003; 278: 47291 – 47298.
77. Sorescu GP, Song H, Tressel SL, Hwang J, Dikalov S, Smith DA, et al. Bone morphogenic protein 4 produced in endothelial cells by oscillatory shear stress induces monocyte adhesion by stimulating reactive oxygen species production from a nox1-based NADPH oxidase. Circ Res 2004; 95: 773 – 779.
78. Kirk EA, Dinauer MC, Rosen H, Chait A, Heinecke JW, LeBoeuf RC. Impaired superoxide production due to a deficiency in phagocyte NADPH oxidase fails to inhibit atherosclerosis in mice. Arterioscler Thromb Vasc Biol 2000; 20: 1529 – 1535.
79. Hsich E, Segal BH, Pagano PJ, Rey FE, Paigen B, Deleonardis J, et al. Vascular effects following homozygous disruption of p47(phox): An essential component of NADPH oxidase. Circulation 2000; 101: 1234 – 1236.
80. Barry-Lane PA, Patterson C, van der Merwe M, Hu Z, Holland SMYeh ET., et al, p47phox is required for atherosclerotic lesion progression in ApoE(−/−) mice. J Clin Invest 2001; 108: 1513 – 1522.
81. Ait-Oufella H, Salomon BL, Potteaux S, Robertson AKL, Gourdy P, Zoll J, et al. Natural regulatory T cells control the development of atherosclerosis in mice. Nat Med 2006; 12: 178 – 180.
82. van Es T, van Puijvelde GHM, Foks AC, Habets KLL, Bot I, Gilboa E, et al. Vaccination against Foxp3(+) regulatory T cells aggravates atherosclerosis. Atherosclerosis 2010; 209: 74 – 80.
83. Klingenberg R, Gerdes N, Badeau RM, Gisterå A, Strodthoff D, Ketelhuth DFJ, et al. Depletion of FOXP3+ regulatory T cells promotes hypercholesterolemia and atherosclerosis. J Clin Invest 2013; 123: 1323 – 1334.
84. de Boer OJ, van der Meer JJ, Teeling P, van der Loos CM, van der Wal AC. Low numbers of FOXP3 positive regulatory T cells are present in all developmental stages of human atherosclerotic lesions. PLoS One 2007; 2: e779, doi:10.1371/journal.pone.0000779.
85. Maganto-Garcia E, Tarrio ML, Grabie N, Bu DX, Lichtman AH. Dynamic changes in regulatory T Cells are linked to levels of dietinduced hypercholesterolemia. Circulation 2011; 124: 185 – 195.
86. Wang Z, Mao S, Zhan Z, Yu K, He C, Wang C. Effect of hyperlipidemia on Foxp3 expression in apolipoprotein E-knockout mice. J Cardiovasc Med (Hagerstown) 2014; 15: 273 – 279.
87. − T cells. Retrovirology 2007; 4: 57.
88. Kraaij MD, Savage NDL, van der Kooij SW, Koekkoek K, Wang J, van den Berg JM, et al. Induction of regulatory T cells by macrophages is dependent on production of reactive oxygen species. Proc Natl Acad Sci USA 2010; 107: 17686 – 17691.
89. Lee K, Won HY, Bae MA, Hong JH, Hwang ES. Spontaneous and aging-dependent development of arthritis in NADPH oxidase 2 deficiency through altered differentiation of CD11b+ and Th/Treg cells. Proc Natl Acad Sci USA 2011; 108: 9548 – 9553.
90. Kim HR, Lee A, Choi EJ, Kie JH, Lim W, Lee HK, et al. Attenuation of experimental colitis in glutathione peroxidase 1 and catalase double knockout mice through enhancing regulatory T cell function. PLoS One 2014; 9: e95332, doi:10.1371/journal.pone.0095332.
91. Schreml S, Szeimies RM, Prantl L, Karrer S, Landthaler M, Babilas P. Oxygen in acute and chronic wound healing. Br J Dermatol 2010; 163: 257 – 268.
92. Knighton DR, Hunt TK, Scheuenstuhl H, Halliday BJ, Werb Z, Banda MJ. Oxygen tension regulates the expression of angiogenesis factor by macrophages. Science 1983; 221: 1283 – 1285.
93. Hopf HW, Gibson JJ, Angeles AP, Constant JS, Feng JJ, Rollins MD, et al. Hyperoxia and angiogenesis. Wound Repair Regen 2005; 13: 558 – 564.
94. Sen CK, Khanna S, Babior BM, Hunt TK, Ellison EC, Roy S. Oxidant-induced vascular endothelial growth factor expression in human keratinocytes and cutaneous wound healing. J Biol Chem 2002; 277: 33284 – 33290.
95. Nespereira B, Pérez-Ilzarbe M, Fernández P, Fuentes AM, Páramo JA, Rodríguez JA. Vitamins C and E downregulate vascular VEGF and VEGFR-2 expression in apolipoprotein-E-deficient mice. Atherosclerosis 2003; 171: 67 – 73.
96. Oak MH, El Bedoui J, Schini-Kerth VB. Antiangiogenic properties of natural polyphenols from red wine and green tea. J Nutr Biochem 2005; 16: 1 – 8.
97. Bråkenhielm E, Cao R, Cao Y. Suppression of angiogenesis, tumor growth, and wound healing by resveratrol, a natural compound in red wine and grapes. FASEB J 2001; 15: 1798 – 1800.
98. Koch AE, Cho M, Burrows J, Leibovich SJ, Polverini PJ. Inhibition of production of macrophage-derived angiogenic activity by the anti-rheumatic agents gold sodium thiomalate and auranofin. Biochem Biophys Res Commun 1988; 154: 205 – 212.
99. Koch AE, Cho M, Burrows JC, Polverini PJ, Leibovich SJ. Inhibition of production of monocyte/macrophage-derived angiogenic activity by oxygen free-radical scavengers. Cell Biol Int Rep 1992; 16: 415 – 425.
100. Urao N, Sudhahar V, Kim SJ, Chen GF, McKinney RD, Kojda G, et al. Critical role of endothelial hydrogen peroxide in post-ischemic neovascularization. PLoS One 2013; 8: e57618, doi:10.1371/journal.pone.0057618.
101. Oshikawa J, Urao N, Kim HW, Kaplan N, Razvi M, McKinney R, et al. Extracellular SOD-derived H2O2 promotes VEGF signaling in caveolae/lipid rafts and post-ischemic angiogenesis in mice. PLoS One 2010; 5: e10189, doi:10.1371/journal.pone.0010189.
102. Arbiser JL, Petros J, Klafter R, Govindajaran B, McLaughlin ER, Brown LF, et al. Reactive oxygen generated by Nox1 triggers the angiogenic switch. Proc Natl Acad Sci USA 2002; 99: 715 – 720.
103. Xia C, Meng Q, Liu LZ, Rojanasakul Y, Wang XR, Jiang BH. Reactive oxygen species regulate angiogenesis and tumor growth through vascular endothelial growth factor. Cancer Res 2007; 67: 10823 – 10830.
104. Zhang M, Brewer AC, Schröder K, Santos CXC, Grieve DJ, Wang M, et al. NADPH oxidase-4 mediates protection against chronic load-induced stress in mouse hearts by enhancing angiogenesis. Proc Natl Acad Sci USA 2010; 107: 18121 – 18126.
105. Vestweber D. VE-cadherin: The major endothelial adhesion molecule controlling cellular junctions and blood vessel formation. Arterioscler Thromb Vasc Biol 2008; 28: 223 – 232.
106. Lamalice L, Le Boeuf F, Huot J. Endothelial cell migration during angiogenesis. Circ Res 2007; 100: 782 – 794.
107. Yamaoka-Tojo M, Ushio-Fukai M, Hilenski L, Dikalov SI, Chen YE, Tojo T, et al. IQGAP1, a novel vascular endothelial growth factor receptor binding protein, is involved in reactive oxygen species--dependent endothelial migration and proliferation. Circ Res 2004; 95: 276 – 283.
108. Harfouche R, Malak NA, Brandes RP, Karsan A, Irani K, Hussain SNA. Roles of reactive oxygen species in angiopoietin-1/tie-2 receptor signaling. FASEB J 2005; 19: 1728 – 1730.
109. Kim YM, Kim KE, Koh GY, Ho YS, Lee KJ. Hydrogen peroxide produced by angiopoietin-1 mediates angiogenesis. Cancer Res 2006; 66: 6167 – 6174.
110. Ikeda S, Yamaoka-Tojo M, Hilenski L, Patrushev NA, Anwar GM, Quinn MT, et al. IQGAP1 regulates reactive oxygen species-dependent endothelial cell migration through interacting with Nox2. Arterioscler Thromb Vasc Biol 2005; 25: 2295 – 2300.
111. Yamaoka-Tojo M, Tojo T, Kim HW, Hilenski L, Patrushev NA, Zhang L, et al. IQGAP1 mediates VE-cadherin-based cell-cell contacts and VEGF signaling at adherence junctions linked to angiogenesis. Arterioscler Thromb Vasc Biol 2006; 26: 1991 – 1997.
112. Gavard J, Gutkind JS. VEGF controls endothelial-cell permeability by promoting the β-arrestin-dependent endocytosis of VE-cadherin. Nat Cell Biol 2006; 8: 1223 – 1234.
113. Moldovan L, Moldovan NI, Sohn RH, Parikh SA, GoldschmidtClermont PJ. Redox changes of cultured endothelial cells and actin dynamics. Circ Res 2000; 86: 549 – 557.
114. Wu RF, Gu Y, Xu YC, Nwariaku FE, Terada LS. Vascular endothelial growth factor causes translocation of p47phox to membrane ruffles through WAVE1. J Biol Chem 2003; 278: 36830 – 36840.
115. Xu YC, Wu RF, Gu Y, Yang YS, Yang MC, Nwariaku FE, et al. Involvement of TRAF4 in oxidative activation of c-Jun N-terminal kinase. J Biol Chem 2002; 277: 28051 – 28057.
116. Wu RF, Xu YC, Ma Z, Nwariaku FE, Sarosi GA, Terada LS. Subcellular targeting of oxidants during endothelial cell migration. J Cell Biol 2005; 171: 893 – 904.
117. Peshavariya H, Dusting GJ, Jiang F, Halmos LR, Sobey CG, Drummond GR, et al. NADPH oxidase isoform selective regulation of endothelial cell proliferation and survival. Naunyn Schmiedebergs Arch Pharmacol 2009; 380: 193 – 204.
118. Chen K, Kirber MT, Xiao H, Yang Y, Keaney JF Jr. Regulation of ROS signal transduction by NADPH oxidase 4 localization. J Cell Biol 2008; 181: 1129 – 1139.
119. Petry A, Djordjevic T, Weitnauer M, Kietzmann T, Hess J, Görlach A. Nox2 and Nox4 mediate proliferative response in endothelial cells. Antioxid Redox Signal 2006; 8: 1473 – 1484.
120. Datla SR, Peshavariya H, Dusting GJ, Mahadev K, Goldstein BJ, Jiang F. Important role of Nox4 type NADPH oxidase in angio genic responses in human microvascular endothelial cells in vitro. Arterioscler Thromb Vasc Biol 2007; 27: 2319 – 2324.
121. Lee J, Giordano S, Zhang J. Autophagy, mitochondria and oxidative stress: Cross-talk and redox signalling. Biochem J 2012; 441: 523– 540.
122. Wang Q, Liang B, Shirwany NA, Zou MH. 2-Deoxy-D-glucose treatment of endothelial cells induces autophagy by reactive oxygen species-mediated activation of the AMP-activated protein kinase. PLoS One 2011; 6: e17234, doi:10.1371/journal.pone.0017234.
123. Du J, Teng RJ, Guan T, Eis A, Kaul S, Konduri GG, et al. Role of autophagy in angiogenesis in aortic endothelial cells. Am J Physiol Cell Physiol 2012; 302: C383 – C391.
124. Shen W, Tian C, Chen H, Yang Y, Zhu D, Gao P, et al. Oxidative stress mediates chemerin-induced autophagy in endothelial cells. Free Radic Biol Med 2013; 55: 73 – 82.
125. Sessa WC, Pritchard K, Seyedi N, Wang J, Hintze TH. Chronic exercise in dogs increases coronary vascular nitric oxide production and endothelial cell nitric oxide synthase gene expression. Circ Res 1994; 74: 349 – 353.
126. Brendle DC, Joseph LJ, Corretti MC, Gardner AW, Katzel LI. Effects of exercise rehabilitation on endothelial reactivity in older patients with peripheral arterial disease. Am J Cardiol 2001; 87: 324 – 329.
127. Stewart KJ, Hiatt WR, Regensteiner JG, Hirsch AT. Exercise training for claudication. N Engl J Med 2002; 347: 1941 – 1951.
128. Yang HT, Prior BM, Lloyd PG, Taylor JC, Li Z, Laughlin MH, et al. Training-induced vascular adaptations to ischemic muscle. J Physiol Pharmacol 2008; 59(Suppl 7): 57 – 70.
129. Dao VT, Floeren M, Kumpf S, Both C, Peter B, Balz V, et al. Catalase activity prevents exercise-induced up-regulation of vasoprotective proteins in venous tissue. J Cell Mol Med 2011; 15: 2326 – 2334.
130. Lauer N, Suvorava T, Rüther U, Jacob R, Meyer W, Harrison DG, et al. Critical involvement of hydrogen peroxide in exerciseinduced up-regulation of endothelial NO synthase. Cardiovasc Res 2005; 65: 254 – 262.
131. Vogel J, Kruse C, Zhang M, Schröder K. Nox4 supports proper capillary growth in exercise and retina neo-vascularization. J Physiol 2015; 593: 2145 – 2154.